Multi-modality megatherapy with [131I]metaiodobenzylguanidine, high dose melphalan and total body irradiation with bone marrow rescue: Feasibility study of a new strategy for advanced neuroblastoma

This publication has 8 references indexed in Scilit:

• 131I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizes
  British Journal of Cancer, 1992
• Phase I/II study of iodine 131 metaiodobenzylguanidine in chemoresistant neuroblastoma: a United Kingdom Children's Cancer Study Group investigation.
  Journal of Clinical Oncology, 1992
• Optimal scheduling of biologically targeted radiotherapy and total body irradiation with bone marrow rescue for the treatment of systemic malignant disease
  International Journal of Radiation Oncology*Biology*Physics, 1991
• The curability of tumours of differing size by targeted radiotherapy using 131I or 90Y
  Radiotherapy and Oncology, 1991
• Implications of the uptake of 131I-radiolabelled metaiodobenzylguanidine (mIBG) for the targeted radiotherapy of neuroblastoma
  The British Journal of Radiology, 1991
• Radiotherapy improves the outlook for patients older than 1 year with Pediatric Oncology Group stage C neuroblastoma.
  Journal of Clinical Oncology, 1991
• International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma.
  Journal of Clinical Oncology, 1988
• The biodistribution and pharmacokinetics of meta-iodobenzylguanidine in childhood neuroblastoma
  European Journal of Nuclear Medicine and Molecular Imaging, 1988